BRPI0909030A2 - composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. - Google Patents

composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.

Info

Publication number: BRPI0909030A2
Authority: BR; Brazil
Prior art keywords: mycophenolate; pharmaceutical compositions; modified release; release pharmaceutical; processes therefor
Prior art date: 2008-03-05

Application number

BRPI0909030A

Other languages

English (en)

Inventor

Jain Rajesh

Singh Sukhjeet

Original Assignee

Panacea Biotec Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-05

Filing date

2009-03-04

Publication date

2018-03-13

2009-03-04 Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd

2018-03-13 Publication of BRPI0909030A2 publication Critical patent/BRPI0909030A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0909030A 2008-03-05 2009-03-04 composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. BRPI0909030A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN549DE2008		2008-03-05
PCT/IN2009/000148 WO2009110005A2 (en)	2008-03-05	2009-03-04	Modified release pharmaceutical compositions comprising mycophenolate and processes thereof

Publications (1)

Publication Number	Publication Date
BRPI0909030A2 true BRPI0909030A2 (pt)	2018-03-13

Family

ID=40863399

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0909030A BRPI0909030A2 (pt)	2008-03-05	2009-03-04	composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.

Country Status (11)

Country	Link
US (1)	US20110008426A1 (pt)
EP (1)	EP2262483A2 (pt)
JP (1)	JP2011513391A (pt)
KR (1)	KR20100126465A (pt)
CN (1)	CN101969931A (pt)
AU (1)	AU2009220779A1 (pt)
BR (1)	BRPI0909030A2 (pt)
CA (1)	CA2717456A1 (pt)
EA (1)	EA201071035A1 (pt)
MX (1)	MX2010009704A (pt)
WO (1)	WO2009110005A2 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP2009545546A (ja)	2006-08-03	2009-12-24	ニテックファーマアクチエンゲゼルシャフト	リウマチ性疾患の遅延放出型グルココルチコイド治療
DE102007011485A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Darreichungsform mit erschwertem Missbrauch
RU2493830C2 (ru)	2008-01-25	2013-09-27	Грюненталь Гмбх	Лекарственная форма
CN102123701B (zh)	2008-05-09	2013-03-27	格吕伦塔尔有限公司	使用喷雾冻凝步骤制备中间粉末制剂以及最终固体剂型的方法
WO2011009603A1 (en)	2009-07-22	2011-01-27	Grünenthal GmbH	Tamper-resistant dosage form for oxidation-sensitive oploids
ES2534908T3 (es)	2009-07-22	2015-04-30	Grünenthal GmbH	Forma de dosificación de liberación controlada extruida por fusión en caliente
US20120141584A1 (en) *	2009-08-26	2012-06-07	Aptapharma, Inc.	Multilayer Minitablets
WO2011051967A2 (en) *	2009-10-23	2011-05-05	Alkem Laboratories Ltd	Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
ES2486791T3 (es)	2010-09-02	2014-08-19	Grünenthal GmbH	Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
KR20130137627A (ko)	2010-09-02	2013-12-17	그뤼넨탈 게엠베하	음이온성 중합체를 포함하는 내변조성 투여형
CA2839126A1 (en)	2011-07-29	2013-02-07	Grunenthal Gmbh	Tamper-resistant tablet providing immediate drug release
HUE034711T2 (en)	2011-07-29	2018-02-28	Gruenenthal Gmbh	Anti-Abuse, Immediate Release Tablet
JP6117249B2 (ja)	2012-02-28	2017-04-19	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
AR090695A1 (es)	2012-04-18	2014-12-03	Gruenenthal Gmbh	Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
TW201503912A (zh) *	2013-03-19	2015-02-01	Novartis Ag	包含癌莫事（ｅｖｅｒｏｌｉｍｕｓ）之醫藥組合物
BR112015029616A2 (pt)	2013-05-29	2017-07-25	Gruenenthal Gmbh	forma de dosagem resistente à adulteração com perfil de liberação bimodal
EP3003279A1 (en)	2013-05-29	2016-04-13	Grünenthal GmbH	Tamper-resistant dosage form containing one or more particles
CN105682643B (zh)	2013-07-12	2019-12-13	格吕伦塔尔有限公司	含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
EP3073994A1 (en)	2013-11-26	2016-10-05	Grünenthal GmbH	Preparation of a powdery pharmaceutical composition by means of cryo-milling
MX2016014738A (es)	2014-05-12	2017-03-06	Gruenenthal Gmbh	Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
US9872835B2 (en)	2014-05-26	2018-01-23	Grünenthal GmbH	Multiparticles safeguarded against ethanolic dose-dumping
EP3285745A1 (en)	2015-04-24	2018-02-28	Grünenthal GmbH	Tamper-resistant dosage form with immediate release and resistance against solvent extraction
HK1245095A1 (zh)	2015-05-20	2018-08-24	Novartis Ag	依維莫司(everolimus)與達托里昔布(dactolisib)的醫藥組合
TWI722988B (zh) *	2015-06-05	2021-04-01	瑩碩生技醫藥股份有限公司	緩釋性醫藥組合物及其製備方法
WO2017042325A1 (en)	2015-09-10	2017-03-16	Grünenthal GmbH	Protecting oral overdose with abuse deterrent immediate release formulations
EP3445343A1 (en) *	2016-04-21	2019-02-27	Valcuria AB	Composition and method for pretreating cancer
CN110114070A (zh)	2016-11-23	2019-08-09	诺华公司	使用依维莫司(everolimus)、达托里昔布(dactolisib)或二者增强免疫反应的方法
CA3054817A1 (en)	2017-03-13	2018-09-20	Okava Pharmaceuticals, Inc.	Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
CN108066322A (zh) *	2018-02-01	2018-05-25	宁波蒙曼生物科技有限公司	一种吗替麦考酚酯缓释胶囊及其制备方法
WO2019157516A1 (en)	2018-02-12	2019-08-15	resTORbio, Inc.	Combination therapies
US10835489B2 (en)	2018-03-09	2020-11-17	University Of Saskatchewan	Modified release formulations of mycophenolate mofetil
JP2022506007A (ja) *	2018-09-07	2022-01-17	オカヴァファーマシューティカルズ，インコーポレイテッド	ミコフェノール酸活性剤を非ヒト哺乳動物に送達するための方法および組成物
JP6795238B1 (ja) *	2020-06-12	2020-12-02	竹本油脂株式会社	合成繊維用処理剤の製造方法、合成繊維用処理剤、合成繊維、及び合成繊維の製造方法
CN114569570B (zh) *	2022-03-15	2023-03-24	浙江长典药物技术开发有限公司	一种吗替麦考酚酯及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1258143B (it) *	1992-09-11	1996-02-20	Alfa Wassermann Spa	Compresse a cessione programmata contenenti naproxen
GB0124953D0 (en) *	2001-10-17	2001-12-05	Novartis Ag	Organic Compounds
US6913768B2 (en) *	2002-09-24	2005-07-05	Shire Laboratories, Inc.	Sustained release delivery of amphetamine salts
HRP20030324A2 (en) *	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect
AR045957A1 (es) *	2003-10-03	2005-11-16	Novartis Ag	Composicion farmaceutica y combinacion
GB0419355D0 (en) *	2004-08-31	2004-09-29	Novartis Ag	Organic compounds
US20080113031A1 (en) *	2004-09-27	2008-05-15	Joey Moodley	Minicapsule Formulations
AU2007214784A1 (en) *	2006-02-13	2007-08-23	Novartis Ag	High dosage of mycophenolic acid (MPA)

2009
- 2009-03-04 JP JP2010549258A patent/JP2011513391A/ja not_active Withdrawn
- 2009-03-04 BR BRPI0909030A patent/BRPI0909030A2/pt not_active IP Right Cessation
- 2009-03-04 MX MX2010009704A patent/MX2010009704A/es not_active Application Discontinuation
- 2009-03-04 EA EA201071035A patent/EA201071035A1/ru unknown
- 2009-03-04 WO PCT/IN2009/000148 patent/WO2009110005A2/en active Application Filing
- 2009-03-04 US US12/920,512 patent/US20110008426A1/en not_active Abandoned
- 2009-03-04 EP EP09717394A patent/EP2262483A2/en not_active Withdrawn
- 2009-03-04 AU AU2009220779A patent/AU2009220779A1/en not_active Abandoned
- 2009-03-04 CA CA2717456A patent/CA2717456A1/en not_active Abandoned
- 2009-03-04 KR KR1020107022011A patent/KR20100126465A/ko not_active Withdrawn
- 2009-03-04 CN CN2009801078161A patent/CN101969931A/zh active Pending

Also Published As

Publication number	Publication date
US20110008426A1 (en)	2011-01-13
AU2009220779A1 (en)	2009-09-11
CA2717456A1 (en)	2009-09-11
EA201071035A1 (ru)	2011-04-29
CN101969931A (zh)	2011-02-09
JP2011513391A (ja)	2011-04-28
KR20100126465A (ko)	2010-12-01
MX2010009704A (es)	2010-12-20
EP2262483A2 (en)	2010-12-22
WO2009110005A3 (en)	2010-10-14
WO2009110005A2 (en)	2009-09-11

Publication	Publication Date	Title
BRPI0909030A2 (pt)	2018-03-13	composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.
BRPI0918652A2 (pt)	2015-08-25	Composições farmacêuticas e métodos de libração relacionadas.
BRPI0919466A2 (pt)	2015-12-01	composição farmacêutica para liberação modificada
BRPI0910503A2 (pt)	2015-09-29	compostos, composições farmacêuticas e respectivos usos.
BRPI1010772A2 (pt)	2016-11-01	composto,e, composição farmacêutica.
BRPI0909780A2 (pt)	2015-08-11	Composições e métodos para liberação de fármaco
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BR112012012108A2 (pt)	2016-04-05	composição farmacêutica compreendendo propofol
BRPI0718688A2 (pt)	2013-12-24	Composições de baixa irritação e métodos para preparar as mesmas.
BRPI0818732A2 (pt)	2014-10-07	Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.
BRPI0913447A2 (pt)	2015-12-01	composição de éster, e, composição para cuidado pessoal.
BRPI0917358A2 (pt)	2015-11-17	formulação farmacêutica de liberação controlada e método.
BRPI0815841A2 (pt)	2015-09-01	Métodos e composições para melhoramento de traços preferidos.
BRPI1010301A2 (pt)	2016-03-15	composição.
BRPI1009372A2 (pt)	2016-05-31	compostos, composição farmacêutica e respectivos usos
DK2285357T3 (da)	2014-06-02	Farmaceutisk sammensætning omfattende brivaracetam
BRPI0814745A2 (pt)	2014-10-07	Composição de produto.
NL2000690A1 (nl)	2007-12-11	Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine.
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
BRPI0808032A2 (pt)	2014-06-17	Processos para preparar hidroxipivalinaldeído e para preparar neopentil glicol.
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
BR112012003800A2 (pt)	2016-11-22	composição, peptídeo, e formulação farmacêutica.
BR112012000831A2 (pt)	2019-09-24	compostos, composições farmacêuticas e métodos relacionados
BRPI0813922A2 (pt)	2017-05-09	composições de inibição de influenza e métodos.

Legal Events

Date	Code	Title	Description
2018-03-20	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES.
2018-07-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]